Lundbeck CDM is the Custom Development and Manufacturing Division of Lundbeck H/S. With more than 20 years of experience in small molecules, Lundbeck CDM supports its partners in the development and optimization of both processes and analytical methods from Clinical Trials up to the Commercial Phase. Our strong R&D team has a green chemistry approach used to develop processes that are suitable for industrialization; we have a strong expertise in dealing with a variety of chemical reactions such as alogenation, hydrogenation, different metal-catalysed cross couplings and enantioselective resolution. Our Quality Unit constitutes the 20% of the company and supports our customers in the Validation of both Analytical Methods and Processes, as well as for DMF preparation and submission. Our Analytical labs in R&D and Quality Control are fully GMP approved. Our Pilot Plant has a capacity of 1,800m3 and can provide different size reactors from 150m3 up to 800m3. In addition, Hastelloy, Stainless Steel and Glass-lined reactors are also present, to meet any organic chemistry requirement. Our Production Plant is also full GMP and has 36 reactors, from 2,000m3 up to 9,000m3 and again a selection of reactors in different materials are available. A new, state-of-the-art production line is in this moment under completion and will increase our capacity of 10% by mid 2023. Flexibility and open-mindset complete the offer that Lundbeck CDM division can provide.